BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33944901)

  • 1. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
    Kadin ME; Xu H; Hunsicker LM; Guan Y
    Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Wei W; Song Z; Yang Y
    Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
    Kadin ME; Adams WP; Inghirami G; Di Napoli A
    Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
    Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2020 Aug; 44(4):1109-1115. PubMed ID: 32766915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Xu H; Glicksman CA
    Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
    Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
    Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A
    Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
    Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
    Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
    Fitzal F; Turner SD; Kenner L
    Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Implant-associated Anaplastic Large Cell Lymphoma.
    Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Ghosh T; Duncavage E; Mehta-Shah N; McGuire PA; Tenenbaum M; Myckatyn TM
    Aesthet Surg J; 2020 Nov; 40(12):1288-1300. PubMed ID: 31894234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.
    de Boer M; van der Sluis WB; de Boer JP; Overbeek LIH; van Leeuwen FE; Rakhorst HA; van der Hulst RRWJ; Hijmering NJ; Bouman MB; de Jong D
    Aesthet Surg J; 2017 Sep; 37(8):NP83-NP87. PubMed ID: 29036941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    Eur J Surg Oncol; 2021 Feb; 47(2):199-210. PubMed ID: 33358076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on: Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
    Miranda RN; Marques-Piubelli ML
    Aesthet Surg J; 2022 Jan; 42(2):NP130-NP132. PubMed ID: 34048544
    [No Abstract]   [Full Text] [Related]  

  • 20. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
    Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
    Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.